Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Total Liabilities (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Total Liabilities for 2 consecutive years, with $82.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Liabilities fell 65.07% to $82.6 million in Q4 2025 year-over-year; TTM through Oct 2025 was $82.6 million, a 65.07% decrease, with the full-year FY2025 number at $90.3 million, up 15.5% from a year prior.
  • Total Liabilities was $82.6 million for Q4 2025 at Kestra Medical Technologies, up from $82.1 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $236.5 million in Q4 2024 to a low of -$196.9 million in Q1 2024.